High density lipoprotein-binding protein, also known as vigilin, is a 110-kD protein that specifically binds HDL molecules and may function in the removal of excess cellular cholesterol.[supplied by OMIM][3]
References
↑McKnight GL, Reasoner J, Gilbert T, Sundquist KO, Hokland B, McKernan PA, Champagne J, Johnson CJ, Bailey MC, Holly R, et al. (Jul 1992). "Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells". J Biol Chem. 267 (17): 12131–41. PMID1318310.
↑Xia YR, Klisak I, Sparkes RS, Oram J, Lusis AJ (Jul 1993). "Localization of the gene for high-density lipoprotein binding protein (HDLBP) to human chromosome 2q37". Genomics. 16 (2): 524–5. doi:10.1006/geno.1993.1221. PMID8390966.
Anderson NL, Anderson NG (2003). "The human plasma proteome: history, character, and diagnostic prospects". Mol. Cell. Proteomics. 1 (11): 845–67. doi:10.1074/mcp.R200007-MCP200. PMID12488461.
Graham DL, Oram JF (1987). "Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting". J. Biol. Chem. 262 (16): 7439–42. PMID3034894.
Plenz G, Kügler S, Schnittger S, et al. (1994). "The human vigilin gene: identification, chromosomal localization and expression pattern". Hum. Genet. 93 (5): 575–82. doi:10.1007/BF00202827. PMID8168838.
Neu-Yilik G, Zorbas H, Gloe TR, et al. (1993). "Vigilin is a cytoplasmic protein. A study on its expression in primary cells and in established cell lines of different species". Eur. J. Biochem. 213 (2): 727–36. doi:10.1111/j.1432-1033.1993.tb17813.x. PMID8477745.
Kügler S, Grünweller A, Probst C, et al. (1996). "Vigilin contains a functional nuclear localisation sequence and is present in both the cytoplasm and the nucleus". FEBS Lett. 382 (3): 330–4. doi:10.1016/0014-5793(96)00204-9. PMID8605996.
Kügler S, Plenz G, Müller PK (1996). "Two additional 5' exons in the human Vigilin gene distinguish it from the chicken gene and provide the structural basis for differential routes of gene expression". Eur. J. Biochem. 238 (2): 410–7. doi:10.1111/j.1432-1033.1996.0410z.x. PMID8681952.
Chiu DS, Oram JF, LeBoeuf RC, et al. (1998). "High-density lipoprotein-binding protein (HBP)/vigilin is expressed in human atherosclerotic lesions and colocalizes with apolipoprotein E.". Arterioscler. Thromb. Vasc. Biol. 17 (11): 2350–8. doi:10.1161/01.ATV.17.11.2350. PMID9409201.
Bocharov AV, Vishnyakova TG, Baranova IN, et al. (2001). "Characterization of a 95 kDa high affinity human high density lipoprotein-binding protein". Biochemistry. 40 (14): 4407–16. doi:10.1021/bi001503k. PMID11284697.
Wistow G, Bernstein SL, Ray S, et al. (2002). "Expressed sequence tag analysis of adult human iris for the NEIBank Project: steroid-response factors and similarities with retinal pigment epithelium". Mol. Vis. 8: 185–95. PMID12107412.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Vollbrandt T, Willkomm D, Stossberg H, Kruse C (2004). "Vigilin is co-localized with 80S ribosomes and binds to the ribosomal complex through its C-terminal domain". Int. J. Biochem. Cell Biol. 36 (7): 1306–18. doi:10.1016/j.biocel.2003.11.006. PMID15109574.